Questa traduzione è in preparazione. Nel frattempo mostriamo temporaneamente la versione originale in inglese.
Imprese · 07/08/20081 min di lettura
Draft Guidance for Industry on Residual Solvents in Drug Products Marketed in the United States; Availability
Traduzione automatica locale · Lingua originale della fonte
Riepilogo
The Food and Drug Administration (FDA) is announcing the availability of a draft guidance for industry entitled "Control of Residual Solvents in Drug Products Marketed in the United States." On July 1, 2008, the United States Pharmacopeia (USP) published a new test requirement for the control of residual solvents, General Chapter "Residual Solvents," which replaced USP General Chapter "Organic Volatile Impurities." The change affects all compendial drug products marketed in the United States. This draft guidance reflects FDA's recommendations on how to comply with those USP changes.
Lingua originale della fonte: Federal Register — Food and Drug AdministrationApri il comunicato originale →